Literature DB >> 32599467

Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis.

Shahin Alizadeh-Fanalou1, Fatemeh Alian2, Mina Mohammadhosayni3, Dariush Rahban4, Pedram Abbasi Ghasem Kheyli5, Majid Ahmadi6.   

Abstract

BACKGROUND: Impaired elimination mechanisms of the autoreactive lymphocytes, like T lymphocytes, via apoptosis may be the cause of continues inflammatory state in multiple sclerosis (MS). BIRC5 gene codify for the survivin, which participates in the modulation of apoptosis and cell survival. The objective of this study was investigation of the role of important confirmed miRNAs, including miR-335, miR-485, miR-542, and miR-708, in the regulation of survivin mRNA in the CD4+ T cells of MS cases.
METHODS: In this study, 50 RRMS patients as well as 50 healthy matched controls were recruited. The peripheral blood mononuclear cells (PBMCs) were isolated from whole blood samples and CD4+ T cells were prepared. After that, RNA was extracted, cDNA was synthesized, and the expression levels of miR-335, miR-485, miR-542, and miR-708 were measured using Real-time PCR. Moreover, the mRNA expression of survivin was detected. Serum level of survivin was detected using ELISA.
RESULTS: The mRNA of survivin was 2-folds upregulated in the CD4+ T cells from MS patients in comparison to the healthy controls (P = 0.0053). Serum level of survivin was higher in patients than controls. There was statistically significant downregulation of miR-485 (P = 0.001) and miR-708 (P = 0.011) in CD4+ T cells of patients compared with controls. The miR-485 downregulation had statistically significant correlation with the mRNA expression and serum level of survivin.
CONCLUSION: miRNAs play a role in the regulation of survivin, and therefore apoptosis of CD4+ T cells, and hence are probably participating in a persistent inflammatory condition in MS patients.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Birc5 gene; Microrna; Multiple sclerosis; Survivin

Mesh:

Substances:

Year:  2020        PMID: 32599467     DOI: 10.1016/j.msard.2020.102303

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  6 in total

Review 1.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 2.  Imprinted Genes and Multiple Sclerosis: What Do We Know?

Authors:  Natalia Baulina; Ivan Kiselev; Olga Favorova
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

3.  Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis.

Authors:  Aya A Elkhodiry; Hend M El Tayebi
Journal:  Noncoding RNA Res       Date:  2021-12-07

Review 4.  miR-30d-5p: A Non-Coding RNA With Potential Diagnostic, Prognostic and Therapeutic Applications.

Authors:  Qinlu Zhao; Xin Yuan; Lian Zheng; Miaomiao Xue
Journal:  Front Cell Dev Biol       Date:  2022-01-27

Review 5.  Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.

Authors:  Navid Shomali; Marwah Suliman Maashi; Behzad Baradaran; Amin Daei Sorkhabi; Aila Sarkesh; Hamed Mohammadi; Maryam Hemmatzadeh; Faroogh Marofi; Siamak Sandoghchian Shotorbani; Mostafa Jarahian
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561

Review 6.  Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases.

Authors:  Qiuyu Yang; Guoqing Wang; Feng Zhang
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.